Brief: Xcellbio Granted Bluebird Bio Commercial License, Got Into Supply Agreement For Use Of Co's Proprietary Cell Manufacturing Technology, Avatar
02/04/2025 13:03
April 2 (Reuters) - bluebird bio Inc BLUE.O: XCELLBIO: GRANTED BLUEBIRD BIO COMMERCIAL LICENSE, GOT INTO SUPPLY AGREEMENT FOR USE OF CO'S PROPRIETARY CELL MANUFACTURING TECHNOLOGY, AVATAR Source text: ID:nBw6FKRpSa Further company coverage: BLUE.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on bluebird bio
See all newsBrief: Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital
Brief: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
Brief: Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment